| Financial Year |
March 31 2023 |
| Monetary Funds |
8,272,918,799.64 |
| Held-for-trading Financial Assets |
173,498,061.99 |
| Notes Receivable |
11,361,851.25 |
| Accounts Receivable |
4,894,116,737.19 |
| Advances to Suppliers |
2,001,820,347.20 |
| Other Receivables |
26,043,281,508.61 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
175,698,717.32 |
| Dividend Receivable |
-- |
| Inventories |
166,189,855,220.50 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
15,460,007,786.92 |
| Total Current Assets |
223,046,860,313.30 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
2,955,634,196.34 |
| Investment Properties |
1,805,112,269.32 |
| Fixed Assetes |
5,407,864,245.77 |
| Under-construction Projects |
698,865,713.20 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,497,873,746.21 |
| R&D expenses |
-- |
| Goodwill |
153,445,115.42 |
| Long-Term Deferred and Prepaid Expenses |
377,489,670.71 |
| Deferred Income Tax Assets |
2,285,361,503.87 |
| Other Non-Current Assets |
2,720,012,902.00 |
| Sub-Total of Non-Current Assets |
22,678,597,691.50 |
| Total Assets |
245,725,458,004.80 |
| Short-Term Loans |
464,088,567.98 |
| Trading Financial liabilities |
988,715,800.74 |
| Notes Payable |
446,270,949.87 |
| Accounts Payable |
26,556,693,686.18 |
| Accounts Received In Advance |
1,030,258,282.67 |
| Employee Compensation Payable |
116,138,529.88 |
| Taxes Payable |
6,018,929,764.42 |
| Interest Payable |
1,663,142,475.52 |
| Dividend Payable |
-- |
| Other payables |
29,121,993,881.97 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
25,186,863,066.61 |
| Other Current Liabilities |
10,379,590,604.80 |
| Sub-Total of Current Liabilities |
201,512,676,226.28 |
| Long-term Loans |
9,422,397,631.12 |
| Bonds Payable |
6,338,948,673.97 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
720,151,604.86 |
| Other Non-Current Liabilities |
3,731,102.97 |
| Sub-Total of Non-Current Liabilities |
19,214,346,648.08 |
| Total Liabilities |
220,727,022,874.36 |
| Paid-In Capital(Or Share Stock) |
4,348,163,851.00 |
| Capital Surplus |
4,474,103,821.16 |
| Surplus Reserve |
5,808,189,467.21 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
7,637,531,801.88 |
| Minority Stockholder's Interest |
2,390,053,367.48 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
22,608,381,762.96 |
| Owner's Equity（Stockholder's Equity） |
24,998,435,130.44 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
245,725,458,004.80 |
